GC is a long-time leader in South Korean public health and is a world-class stakeholder of the biopharmaceutical industry.
GC, through its affiliates, provides total healthcare solutions that address the evolving needs of human health. GC was founded in 1967 and is headquartered in Yongin, South Korea. The company is the parent company of GC Pharma (Green Cross Corporation) (KRX: 006280), the largest protein therapeutics manufacturer in Asia.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 18, 2018
Feldan Therapeutics
|
Series A | $13.80M | Biotechnology | Yes |